Abstract
The alarming rates of physical health comorbidity in bipolar disorder, primarily metabolic and cardiovascular illness, place a heavy burden on patient quality of life and healthcare. Despite clear advice and the widespread availability for monitoring and intervention, clinicians continue to overlook the physical health of patients with psychiatric disorders and psychological problems. Therefore, the associations between these chronic mental illnesses and the role of physical health monitoring and intervention strategies warrant evaluation.
The aim of this chapter is to review metabolic and cardiovascular disease monitoring practices in bipolar disorder. In doing so, the links between bipolar disorder, metabolic function, and cardiovascular disease and potential shared illness processes are examined. On the basis of this, clinical and research recommendations are outlined. With greater understanding of the shared illness processes for bipolar disorder and metabolic and cardiovascular dysfunction, improvements in the monitoring and treatment of patients with bipolar disorder may be developed. By considering a shared illness process approach, bipolar disorder-specific solutions for more informative monitoring and targeted healthcare options may be implemented into routine psychiatric practice. This will facilitate better lifelong management of the psychological and physical health of patients with bipolar disorder.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Ahrens B, Grof P, Moller HJ, Müller-Oerlinghausen B, Wolf T (1995) Extended survival of patients on long-term lithium treatment. Can J Psychiatr 40(5):241–246
Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15(7):539–553, http://doi.org/10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
Bengesser SA, Lackner N, Birner A, Fellendorf FT, Platzer M, Mitteregger A et al (2015) Peripheral markers of oxidative stress and antioxidative defense in euthymia of bipolar disorder—gender and obesity effects. J Affect Disord 172:367–374
Berk M, Berk L, Castle D (2004) A collaborative approach to the treatment alliance in bipolar disorder. Bipolar Disord 6(6):504–518, http://doi.org/10.1111/j.1399-5618.2004.00154.x
Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M et al (2011) Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev 35(3):804–817, http://doi.org/10.1016/j.neubiorev.2010.10.001
Birkenaes AB, Opjordsmoen S, Brunborg C, Engh JA, Jonsdottir H, Ringen PA et al (2007) The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: a comparative study. J Clin Psychiatry 68(6):917–923
Byrne N, Regan C, Livingston G (2006) Adherence to treatment in mood disorders. Curr Opin Psychiatry 19(1):44
Cabassa LJ, Ezell JM, Lewis-Fernández R (2010) Lifestyle interventions for adults with serious mental illness: a systematic literature review. Psychiatr Serv 61(8):774–782
Cardenas J, Frye MA, Marusak SL, Levander EM, Chirichigno JW, Lewis S et al (2008) Modal subcomponents of metabolic syndrome in patients with bipolar disorder. J Affect Disord 106(1–2):91–97, http://doi.org/10.1016/j.jad.2007.05.030
Castrogiovanni S, Soreca I, Troiani D, Mauri M (2009) Binge eating, weight gain and psychosocial adjustment in patients with bipolar disorder. Psychiatry Res 169(1):88–90, http://doi.org/10.1016/j.psychres.2008.06.016
Choi J, Joseph L, Pilote L (2013) Obesity and C-reactive protein in various populations: a systematic review and meta-analysis. Obes Rev 14(3):232–244, http://doi.org/10.1111/obr.12003
Chrousos GP (2009) Stress and disorders of the stress system. Nat Rev Endocrinol 5(7):374–381, http://doi.org/10.1038/nrendo.2009.106
Correll CU, Frederickson AM, Kane JM, Manu P (2006) Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugs. J Clin Psychiatry 67(4):575–583
Correll CU, Frederickson AM, Kane JM, Manu P (2008) Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics. Bipolar Disord 10(7):788–797, http://doi.org/10.1111/j.1399-5618.2008.00625.x
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 285(19):2486–2497
Fagiolini A, Kupfer DJ, Houck PR, Novick DM, Frank E (2003) Obesity as a correlate of outcome in patients with bipolar I disorder. Am J Psychiatr 160(1):112–117
Fagiolini A, Frank E, Scott JA, Turkin S, Kupfer DJ (2005) Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disord 7(5):424–430, http://doi.org/10.1111/j.1399-5618.2005.00234.x
Fagiolini A, Chengappa KNR, Soreca I, Chang J (2008) Bipolar disorder and the metabolic syndrome. CNS Drugs 22(8):655–669, http://doi.org/10.2165/00023210-200822080-00004
Fiedorowicz JG, Palagummi NM, Forman-Hoffman VL, Miller DD, Haynes WG (2008) Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder. Ann Clin Psychiatry 20(3):131–137, http://doi.org/10.1080/10401230802177722
Fiedorowicz JG, Solomon DA, Endicott J, Leon AC, Li C, Rice JP, Coryell WH (2009) Manic/hypomanic symptom burden and cardiovascular mortality in bipolar disorder. Psychosom Med 71(6):598–606, http://doi.org/10.1097/PSY.0b013e3181acee26
Garcia-Portilla MP, Sáiz PA, Benabarre A, Sierra P, Perez J, Rodriguez A et al (2008) The prevalence of metabolic syndrome in patients with bipolar disorder. J Affect Disord 106(1–2):197–201, http://doi.org/10.1016/j.jad.2007.06.002
Garcia-Portilla MP, Sáiz PA, Bascaran MT, Martínez AS, Benabarre A, Sierra P et al (2009) Cardiovascular risk in patients with bipolar disorder. J Affect Disord 115(3):302–308, http://doi.org/10.1016/j.jad.2008.09.008
Goldstein BI, Fagiolini A, Houck P, Kupfer DJ (2009) Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States. Bipolar Disord 11(6):657–662, http://doi.org/10.1111/j.1399-5618.2009.00735.x
Grover S, Aggarwal M, Chakrabarti S, Dutt A, Avasthi A, Kulhara P et al (2012) Prevalence of metabolic syndrome in bipolar disorder: an exploratory study from North India. Prog Neuro-Psychopharmacol Biol Psychiatry 36(1):141–146, http://doi.org/10.1016/j.pnpbp.2011.10.013
John AP, Koloth R, Dragovic M, Lim SCB (2009) Prevalence of metabolic syndrome among Australians with severe mental illness. Med J Aust 190(4):176–179
Kallner G, Lindelius R, Petterson U, Stockman O, Tham A (2000) Mortality in 497 patients with affective disorders attending a lithium clinic or after having left it. Pharmacopsychiatry 33(1):8–13, http://doi.org/10.1055/s-2000-7965
Keck PE, McElroy SL (2003) Bipolar disorder, obesity, and pharmacotherapy-associated weight gain. J Clin Psychiatry 64(12):1426–1435
Kelly EL, Fenwick KM, Barr N, Cohen H, Brekke JS (2014) A systematic review of self-management health care models for individuals with serious mental illnesses. Psychiatr Serv 65(11):1300–1310, http://doi.org/10.1176/appi.ps.201300502
Kemp AH, Quintana DS (2013) The relationship between mental and physical health: insights from the study of heart rate variability. Int J Psychophysiol 89(3):288–296, http://doi.org/10.1016/j.ijpsycho.2013.06.018
Kemp DE, Eudicone JM, McQuade RD, Chambers JS, Baker RA (2010) Metabolic syndrome and its potential effect on treatment response to aripiprazole a post hoc analysis of the stabilization phase of a long-term, double-blind study in patients with bipolar disorder (CN138-010). J Clin Psychopharmacol 30(5):631–634, http://doi.org/10.1097/JCP.0b013e3181f0569f
Lakka H, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288(21):2709–2716
Lee NY, Kim SH, Cho B, Lee YJ, Chang JS, Kang UG et al (2010) Patients taking medications for bipolar disorder are more prone to metabolic syndrome than Korea’s general population. Prog Neuro-Psychopharmacol Biol Psychiatry 34(7):1243–1249, http://doi.org/10.1016/j.pnpbp.2010.06.029
Maina G, Salvi V, Vitalucci A, D’Ambrosio V, Bogetto F (2008) Prevalence and correlates of overweight in drug-naïve patients with bipolar disorder. J Affect Disord 110(1–2):149–155, http://doi.org/10.1016/j.jad.2007.12.233
Malik S, Wong ND, Franklin SS, Kamath TV, L’Italien GJ, Pio JR, Williams GR (2004) Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in united states adults. Circulation 110(10):1245–1250, http://doi.org/10.1161/01.CIR.0000140677.20606.0E
Mansur RB, Brietzke E, McIntyre RS (2015) Is there a “metabolic-mood syndrome?” A review of the relationship between obesity and mood disorders. Neurosci Biobehav Rev 52:89–104, http://doi.org/10.1016/j.neubiorev.2014.12.017
Mayer EA, Fanselow MS (2003) Dissecting the components of the central response to stress. Nat Neurosci 6(10):1011–1012, http://doi.org/10.1038/nn1003-1011
McElroy SL, Frye MA, Suppes T, Dhavale D, Keck PEJ, Leverich GS et al (2002) Correlates of overweight and obesity in 644 patients with bipolar disorder. J Clin Psychiatry 63(3):207–213
McElroy SL, Frye MA, Hellemann G, Altshuler L, Leverich GS, Suppes T et al (2011) Prevalence and correlates of eating disorders in 875 patients with bipolar disorder. J Affect Disord 128(3):191–198, http://doi.org/10.1016/j.jad.2010.06.037
McElroy SL, Kemp DE, Friedman ES, Reilly-Harrington NA, Sylvia LG, Calabrese JR et al (2015) Obesity, but not metabolic syndrome, negatively affects outcome in bipolar disorder. Acta Psychiatr Scand 133(2):144–153, http://doi.org/10.1111/acps.12460
McIntyre RS, Danilewitz M, Liauw SS, Kemp DE, Nguyen HTT, Kahn LS et al (2010) Bipolar disorder and metabolic syndrome: an international perspective. J Affect Disord 126(3):366–387
Murray DP, Weiner M, Prabhakar M, Fiedorowicz JG (2009) Mania and mortality: why the excess cardiovascular risk in bipolar disorder? Curr Psychiatr Rep 11(6):475–480
Murray G, Suto M, Hole R, Hale S, Amari E, Michalak EE (2010) Self-management strategies used by “high functioning” individuals with bipolar disorder: from research to clinical practice. Clin Psychol Psychother 18(2):95–109, http://doi.org/10.1002/cpp.710
Murray DP, Metz NS, Haynes WG, Fiedorowicz JG (2012) Vascular function is not impaired early in the course of bipolar disorder. J Psychosom Res 72(3):195–198, http://doi.org/10.1016/j.jpsychores.2011.12.006
Nemeroff CB (2003) Safety of available agents used to treat bipolar disorder: focus on weight gain. J Clin Psychiatry 64(5):532–539
NICE (2006) Bipolar disorder: the management of bipolar disorder in adults, children and adolescents, in primary and secondary care: clinical guideline 38. National Institute of Health and Care Excellence, London
NICE (2015) Bipolar disorder: the assessment and management of bipolar disorder in adults, children and young people in primary and secondary care. NICE clinical guideline 185. National Institute of Health and Care Excellence, London
Outhred T, Kemp AH, Malhi GS (2014) Physiological correlates of bipolar spectrum disorders and their treatment. In: Kumari V, Boutros N, Bob P (eds) Current topics in behavioral neurosciences. Springer, Berlin, pp 1–56, http://doi.org/10.1007/7854_2014_297
Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37(12):1595–1607
Redlich C, Berk M, Williams LJ, Sundquist J, Sundquist K, Li X (2014) Statin use and risk of depression: a Swedish national cohort study. BMC Psychiatr 14:348, http://doi.org/10.1186/s12888-014-0348-y
Russell SJ, Browne JL (2005) Staying well with bipolar disorder. Aust N Z J Psychiatry 39(3):187–193, http://doi.org/10.1111/j.1440-1614.2005.01542.x
Sodhi SK, Linder J, Chenard CA, Miller DD, Haynes WG, Fiedorowicz JG (2012) Evidence for accelerated vascular aging in bipolar disorder. J Psychosom Res 73(3):175–179, http://doi.org/10.1016/j.jpsychores.2012.06.004
Stafford L, Berk M (2011) The use of statins after a cardiac intervention is associated with reduced risk of subsequent depression: proof of concept for the inflammatory and oxidative hypotheses of depression? J Clin Psychiatry 72(9):1229–1235, http://doi.org/10.4088/JCP.09m05825blu
Taylor V, MacQueen G (2006) Associations between bipolar disorder and metabolic syndrome: a review. J Clin Psychiatry 67(7):1034–1041
Theisen FM, Linden A, König IR, Martin M, Remschmidt H, Hebebrand J (2003) Spectrum of binge eating symptomatology in patients treated with clozapine and olanzapine. J Neural Transm 110(1):111–121, http://doi.org/10.1007/s00702-002-0792-6
Vancampfort D, Vansteelandt K, Correll CU, Mitchell AJ, De Herdt A, Sienaert P et al (2013) Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators. Am J Psychiatr 170(3):265–274, http://doi.org/10.1176/appi.ajp.2012.12050620
Weiner M, Warren L, Fiedorowicz JG (2011) Cardiovascular morbidity and mortality in bipolar disorder. Ann Clin Psychiatry 23(1):40–47
Wildes JE, Marcus MD, Fagiolini A (2008) Prevalence and correlates of eating disorder co-morbidity in patients with bipolar disorder. Psychiatry Res 161(1):51–58, http://doi.org/10.1016/j.psychres.2007.09.003
Wong ND, Pio JR, Franklin SS, L’Italien GJ, Kamath TV, Williams GR (2003) Preventing coronary events by optimal control of blood pressure and lipids in patients with the metabolic syndrome. Am J Cardiol 91(12):1421–1426
Yilmaz J, Povey L, Dalgliesh J (2011) Adopting a psychological approach to obesity. Nurs Stand 25(21):42–46, http://doi.org/10.7748/ns2011.01.25.21.42.c8289
Yumru M, Savas HA, Kurt E, Kaya MC, Selek S, Savas E et al (2007) Atypical antipsychotics related metabolic syndrome in bipolar patients. J Affect Disord 98(3):247–252, http://doi.org/10.1016/j.jad.2006.08.009
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Outhred, T., McAulay, C., Gessler, D., Malhi, G.S. (2016). Monitoring for Metabolic Dysfunction and Cardiovascular Disease in Bipolar Disorder: A Shared Illness Process Approach. In: Baune, B., Tully, P. (eds) Cardiovascular Diseases and Depression. Springer, Cham. https://doi.org/10.1007/978-3-319-32480-7_19
Download citation
DOI: https://doi.org/10.1007/978-3-319-32480-7_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-32478-4
Online ISBN: 978-3-319-32480-7
eBook Packages: MedicineMedicine (R0)